当前位置:首页 - 行情中心 - 近岸蛋白(688137) - 财务分析 - 资产负债表

近岸蛋白

(688137)

  

流通市值:35.24亿  总市值:35.24亿
流通股本:7017.54万   总股本:7017.54万

资产负债表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
流动资产:
  货币资金772,935,579.79711,099,853.7799,160,034.99773,904,943.18
  应收票据及应收账款64,414,373.7261,767,798.6771,420,745.1966,799,942.38
  其中:应收票据--140,000250,000
        应收账款64,414,373.7261,767,798.6771,280,745.1966,549,942.38
  应收款项融资153,0306,600258,4604,292,884
  预付款项3,650,6532,955,589.163,202,662.063,347,666.46
  其他应收款合计7,284,321.83,655,721.973,696,271.14,046,916.43
  存货70,510,884.2563,315,995.8868,473,483.7566,165,222.94
  其他流动资产916,482,354.461,012,166,579.01967,431,478.531,000,855,940.07
  流动资产合计1,835,431,197.021,854,968,138.391,913,643,135.621,919,413,515.46
非流动资产:
  其他非流动金融资产13,000,00010,000,00010,000,00010,000,000
  固定资产69,053,536.3144,610,184.835,952,058.8336,977,565.09
  在建工程85,177,793.67132,219,642.85120,162,405.07116,484,240.04
  使用权资产37,260,757.339,588,701.5438,294,653.3942,415,241.91
  无形资产17,643,039.4417,771,929.217,900,818.9418,029,708.7
  长期待摊费用48,669,526.556,605,257.518,888,125.69,517,922.08
  递延所得税资产24,664,912.6323,809,531.0840,791,45935,846,161.8
  其他非流动资产14,984,517.7621,975,262.039,605,889.339,813,463.78
  非流动资产合计310,454,083.66296,580,509.01281,595,410.16279,084,303.4
  资产总计2,145,885,280.682,151,548,647.42,195,238,545.782,198,497,818.86
流动负债:
  应付票据及应付账款48,534,164.3736,227,836.540,526,183.0440,732,884.45
        应付账款48,534,164.3736,227,836.540,526,183.0440,732,884.45
  合同负债6,150,432.745,847,068.455,750,772.075,127,156.91
  应付职工薪酬12,486,603.0113,371,756.3311,955,903.5210,580,258.87
  应交税费341,812.681,881,271.763,161,421.42,699,511.31
  其他应付款合计1,562,140.691,533,575.091,299,554.841,018,790.44
  一年内到期的非流动负债9,148,662.089,482,967.349,357,265.1111,985,178.55
  其他流动负债808,523.43777,574.122,489,366.071,879,260.43
  流动负债合计79,032,33969,122,049.5974,540,466.0574,023,040.96
非流动负债:
  租赁负债43,399,504.0545,601,398.9739,022,428.0241,175,293.24
  预计负债911,243.23551,137.26--
  递延收益1,505,696.81,551,797.871,218,7501,239,000
  非流动负债合计45,816,444.0847,704,334.140,241,178.0242,414,293.24
  负债合计124,848,783.08116,826,383.69114,781,644.07116,437,334.2
所有者权益(或股东权益):
  实收资本(或股本)70,175,43970,175,43970,175,43970,175,439
  资本公积1,977,279,985.951,975,662,498.811,972,545,136.11,969,541,560.31
  减:库存股16,781,489.6711,956,091.211,956,091.211,956,091.2
  其他综合收益393,573.27267,060.3194,937.95166,399.01
  盈余公积18,341,366.7618,341,366.7618,341,366.7618,341,366.76
  未分配利润-28,372,377.71-17,768,009.9631,156,113.135,791,810.78
  归属于母公司股东权益合计2,021,036,497.62,034,722,263.712,080,456,901.712,082,060,484.66
  股东权益合计2,021,036,497.62,034,722,263.712,080,456,901.712,082,060,484.66
  负债和股东权益合计2,145,885,280.682,151,548,647.42,195,238,545.782,198,497,818.86
公告日期2026-04-292026-04-292025-10-302025-08-28
审计意见(境内)标准无保留意见
TOP↑